Riskpilot← Back to searchSign inGet full accessMesoskinline ApS
APSActiveCVR 39967065Juelsmindevej 57Wholesale of perfume and cosmetics · NACE 4645Est. 20184 employees
Revenue 2024
DKK 793K
-51% vs 2023
EBITDA margin
29.9%
-78% vs 2023
Equity ratio
53.3%
Financial strength
Net profit 2024
DKK -20K
-103% vs 2023
| Revenue | DKK 793K | -51% |
| EBITDA | DKK 237K | -78% |
| Net profit | DKK -20K | -103% |
| Total assets | DKK 3,6M | -16% |
| Equity | DKK 1,9M | -1% |
| Employees | 4 | — |
Legal name
Mesoskinline ApS
CVR number
39967065
Legal form
Anpartsselskab
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
24. oktober 2018
Share capital
DKK 75.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive fabrikation og handel, herunder med kosmetikvarer og produkter til personlig pleje, samt at drive virksomhed med skønheds- og hudpleje.
Address
Juelsmindevej 57
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 785 | 1.018 | 1.917 | 1.628 | 793 |
| Staff expenses | -0 | -473 | -201 | -531 | -556 |
| EBITDA | 785 | 545 | 1.717 | 1.097 | 237 |
| Depreciation & amort. | -63 | -82 | -141 | -155 | -166 |
| EBIT | 722 | 463 | 1.575 | 942 | 72 |
| Net financials | -66 | -27 | -47 | -36 | -91 |
| Profit before tax | 657 | 436 | 1.529 | 906 | -20 |
| Tax | 150 | 97 | 341 | 202 | 0 |
| Net profit | 506 | 339 | 1.187 | 703 | -20 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.984 | 2.854 | 3.906 | 4.316 | 3.619 |
| Equity | 1.120 | 1.459 | 2.246 | 1.950 | 1.930 |
| Long-term debt | 0 | 0 | 0 | 0 | 7 |
| Short-term debt | 858 | 1.384 | 1.657 | 2.366 | 1.682 |
| Total debt | 858 | 1.384 | 1.657 | 2.366 | 1.689 |
EBITDA margin
29.9%
This company
15.8%
Market median
+89% vs market
20202024
Equity ratio
53.3%
This company
38.2%
Market median
+40% vs market
20202024
Return on equity
-1.0%
This company
18.4%
Market median
-105% vs market
20202024
Net profit margin
-2.5%
This company
8.1%
Market median
-131% vs market
20202024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20202024
Debt / equity
0.88×
This company
0.62×
Market median
+42% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AK Management | Management | 2018 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 90–99.99% | 90–99.99% | 2025 | |
| Individual | 5–9.99% | 5–9.99% | 2025 | |
| Company | 5–9.99% | 5–9.99% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mesoskinline ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aleksandra Kjærsfeldt | Management | 0 companies |